Cambridge Investment Research Advisors’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
Other funds holding MDXG
EWM
TI
FLAM
PCMI
CC
Cambridge Investment Research Advisors's MDXG Position: Q3 2025 in Review
Cambridge Investment Research Advisors sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 11,380 shares — an estimated $70K sold.
Cambridge Investment Research Advisors first reported a position in MDXG in Q3 2014 and held it in 15 quarters. The position peaked at $842K in Q4 2017. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.
- Cambridge Investment Research Advisors reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 11,380 MiMedx Group shares in Q3 2025, an estimated $70K.
- Cambridge Investment Research Advisors first reported a position in MiMedx Group in Q3 2014 and held it in 15 quarters.
- Cambridge Investment Research Advisors's MiMedx Group position peaked at $842K in Q4 2017.
- 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.